2025-522966-61-00CompletedPhase 1
A clinical study to investigate the safety, tolerability and pharmacokinetic profile of single ascending concentrations of OPT101 in peritoneal dialysis patients.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 9 Jan 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- First submitted
- 10 Sept 2025
- Start date
- 16 Feb 2026
- Lead sponsor
- OPTERION Health AG
- Diseases
- Chronic kidney disease
- EU CT number
- 2025-522966-61-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 12
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pauls Stradins Clinical University Hospital | Riga | Latvia | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.